1887

Abstract

Summary

A 1·4 kb fragment (nucleotides 2430 to 3901) encoding portions of the human parvovirus B19 structural proteins was inserted into the pRIT2 plasmid expression vector containing the gene encoding staphylococcal Protein A under the control of the phage promoter P. The fusion protein was used to raise antibodies in rabbits. The sera were shown by immune electron microscopy to agglutinate B19 particles and were also shown to recognize the VP2 B19 capsid protein, by Western blot analysis. The B19 antigenicity of the fusion protein was confirmed by immunoblot and enzyme immunoassay with IgG and IgM anti-B19-positive reference human sera.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-70-11-3091
1989-11-01
2021-10-22
Loading full text...

Full text loading...

/deliver/fulltext/jgv/70/11/JV0700113091.html?itemId=/content/journal/jgv/10.1099/0022-1317-70-11-3091&mimeType=html&fmt=ahah

References

  1. Anand A., Gray E. S., Brown T., Clewley J. P., Cohen B. J. 1987; Human parvovirus infection in pregnancy and hydrops fetalis. New England Journal of Medicine 316:183–186
    [Google Scholar]
  2. Anderson M. J., Lewis E., Kidds I. M., Hall S. M., Cohen B. I. 1984; An outbreak of erythema infectiosum associated with human parvovirus infection. Journal of Hygiene 93:85–93
    [Google Scholar]
  3. Blundell M. C., Beard C., Astell C. R. 1987; In vitro identification of a B19 parvovirus promoter. Virology 157:534–538
    [Google Scholar]
  4. Brown T. A., Anand A., Ritchie L. D., Clewley J. P., Reid M. S. 1984; Intrauterine parvovirus infection associated with hydrops fetalis. Lancet ii:1033–1034
    [Google Scholar]
  5. Clewley J. P. 1984; Biochemical characterization of a human parvovirus. Journal of General Virology 65:241–245
    [Google Scholar]
  6. Cossart Y. E., Cant B., Field A. M., Widdows D. 1975; Parvovirus-like particles in human serum. Lancet i72–73
    [Google Scholar]
  7. Cotmore S. F., Tattersall P. 1984; Characterization and molecular cloning of a human parvovirus genome. Science 226:1161–1165
    [Google Scholar]
  8. Cotmore S. F., Mckle V. C., Anderson M. J., Astell C. R., Tattersall P. 1986; Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments. Journal of Virology 60:548–557
    [Google Scholar]
  9. Holmes D. S., Quigley M. 1981; A rapid boiling method for the preparation of bacterial plasmids. Analytical Biochemistry 114:193–195
    [Google Scholar]
  10. Kurtzman G. J., Ozawa K., Cohen B. J., Hanson G., Oseas R., Young N. S. 1987; Chronic bone marrow failure due to persistent B19 parvovirus infection. New England Journal of Medicine 317:287–294
    [Google Scholar]
  11. Lefrere J. J., Courouce A. M., Muller J. Y., Clark M., Soulier J. P. 1985; Human parvovirus and purpura. Lancet ii730
    [Google Scholar]
  12. Morinet F., Tratschin J. D., Perol Y., Siegl G. 1986; Comparison of 17 isolates for the human parvovirus B19 by restriction enzyme analysis. Brief Report. Archives of Virology 90:165–172
    [Google Scholar]
  13. Morinet F., Monsuez J. J., Roge P., Perol Y. 1987; Parvovirus B19 associated with pseudoappendicitis. Lancet ii1466
    [Google Scholar]
  14. Morrison D. A. 1979; Transformation and preservation of competent bacterial cells by freezing. Methods in Enzymology 68:326–331
    [Google Scholar]
  15. Mortimer P. P., Humphries R. K., Moore J. G., Purcell R. H., Young N. S. 1983; A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature London: 302426–429
    [Google Scholar]
  16. Nilsson B., Abrahmsen L., Uhlen M. 1985; Immobilization and purification of enzymes with staphylococcal protein A gene fusion vectors. EM BO Journal 4:1075–1080
    [Google Scholar]
  17. Ozawa K., Young N. 1987; Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow cell cultures. Journal of Virology 61:2627–2630
    [Google Scholar]
  18. Ozawa K., Kurtzman G., Young N. 1986; Replication of the B19 parvovirus in human bone marrow cell cultures. Science 233:883–886
    [Google Scholar]
  19. Ozawa K., Ayub J., Yu-shu H., Kurtzman G., Shimada T., Young N. 1987; Novel transcription map for the B19 (human) pathogenic parvovirus. Journal of Virology 61:2395–2406
    [Google Scholar]
  20. Pattison J. R., Jones S. E., Hodgson J., Davis L. R., White J. M., Stroud C. E., Murtaza L. 1981; Parvovirus infections and hypoplastic crisis in sickle cell anaemia. Lancet i664–665
    [Google Scholar]
  21. Reid D. M., Brown T., Reid T. M. S., Rennie J. A. N., Eastmond C. J. 1985; Human parvovirus associated arthritis, a clinical and laboratory description. Lancet i422–425
    [Google Scholar]
  22. Sanger F., Nicklen S., Coulson A. R. 1977; DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of SciencesU.S.A 745463–5467
    [Google Scholar]
  23. Shade R. O., Blundell M. C., Cotmore S. F., Tattersall P., Astell C. R. 1986; Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during an aplastic crisis. Journal of Virology 58:921–936
    [Google Scholar]
  24. Shneerson J. M., Mortimer P. P., Vandervelde E. M. 1980; Febrile illness due to parvovirus. British Medical Journal i1580
    [Google Scholar]
  25. Sisk W. P., Berman M. L. 1987; Expression of human parvovirus B19 structural protein in coli and detection of antiviral antibodies in human serum. Bio/Technology 5:1077–1080
    [Google Scholar]
  26. Summers J., Jones S. E., Anderson M. J. 1983; Characterization of the genome of the agent of erythrocyte aplasia permits its classification as a human parvovirus. Journal of General Virology 64:2527–2532
    [Google Scholar]
  27. White D. G., Woolf A. D., Mortimer P. P., Cohen B. J., Blake D. R., Bacon P. A. 1985; Human parvovirus arthropathy. Lancet i419–422
    [Google Scholar]
  28. Young N. S., Harrison M., Moore J., Mortimer P. P., Humphries R. K. 1984; Direct demonstration of the human parvovirus in erythroid progenitor cells infected in vitro. Journal of Clinical Investigation 74:2024–2032
    [Google Scholar]
  29. Zabeau M., Stanley K. K. 1982; Enhanced expression of cro-β-galactosidase fusion proteins under the control of the PR promoter of bacteriophage. EMBO Journal 1:1217–1224
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-70-11-3091
Loading
/content/journal/jgv/10.1099/0022-1317-70-11-3091
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error